Sign In

Robert Cavaliere MD


​ 

Robert Cavaliere MD
Asst Professor - ClinicalCollege of Medicinerobert.cavaliere@osumc.edu
Starling Loving Hall 320 W 10th Avenue Columbus OH 43210
Phone:614-293-4448Fax: 614-366-5763
  • Viral Oncology

General Research Interest

Primary and metastatic brain cancer, quality of life outcomes, experimental therapeutics.

Research Description

• The development of therapies for patients with metastatic and primary brain tumors that prolong and improve their lives. • The evaluation of the processes and treatments currently employed for their true effectiveness and impact on quality of life. • The study of certain high-risk populations (including the elderly and those significantly impaired by their disease) in which the small gains of treatment must be balanced against the increased risk of treatment toxicity and complications.

Transinstitutional Work

Collaboration of all members of the neuro-oncology treatment team, including medical neuro-oncology, neurosurgery and radiation oncology, is critical to the successful delivery of care. For this reason, a multidisciplinary neuro-oncology clinic was established at The James to accommodate patients with such complex diseases. The development of novel therapies to treat brain cancers requires close collaboration with basic scientists, in whose labs drugs are first conceived and tested. Through this partnership, promising agents are identified and translated into clinical studies for patients. Successful care requires team members to address the daily needs of patients: psychological, financial, physical and social needs. Our neuro-oncology nurses, social workers and counselors focus all their attention on these needs.

Current Publications

  • Hafeez S, Cavaliere RRecent innovations in the management of low-grade gliomas.Curr Treat Options Neurol 14(4) 369-80 8/1/2012
  • Goldlust SA, Cavaliere R, Newton HB, Hsu M, Deangelis LM, Batchelor TT, Gilbert MR, Lassman ABBevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors.J Neurooncol 107(2) 407-11 4/1/2012
  • Sheehan JM, Cavaliere R, Farace E, Bredel M, Burri SHGlioblastoma multiforme.Neurol Res Int 2012 819304 1/1/2012
  • Cohen JB, Cavaliere R, Byrd JC, Andritsos LAHearing Loss due to Infiltration of the Tympanic Membrane by Chronic Lymphocytic Leukemia.Case Rep Hematol 2012 589718 1/1/2012
  • Lo SS, Clarke JW, Grecula JC, McGregor JM, Mayr NA, Cavaliere R, Kendra KL, Gupta N, Wang JZ, Sarkar A, Olencki TEStereotactic radiosurgery alone for patients with 1-4 radioresistant brain metastases.Med Oncol 28 Suppl 1 S439-44 12/1/2011
  • Chiocca EA, Aguilar LK, Bell SD, Kaur B, Hardcastle J, Cavaliere R, McGregor J, Lo S, Ray-Chaudhuri A, Chakravarti A, Grecula J, Newton H, Harris KS, Grossman RG, Trask TW, Baskin DS, Monterroso C, Manzanera AG, Aguilar-Cordova E, New PZPhase IB study of gene-mediated cytotoxic immunotherapy adjuvant to up-front surgery and intensive timing radiation for malignant glioma.J Clin Oncol 29(27) 3611-9 9/20/2011